CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
5.93
+0.59 (11.05%)
Jan 27, 2026, 4:00 PM EST - Market closed
CytomX Therapeutics Employees
As of December 31, 2024, CytomX Therapeutics had 121 total employees, including 119 full-time and 2 part-time employees. The number of employees decreased by 1 or -0.82% compared to the previous year.
Employees
121
Change (1Y)
-1
Growth (1Y)
-0.82%
Revenue / Employee
$939,099
Profits / Employee
$231,554
Market Cap
1.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 121 | -1 | -0.82% | 119 | 2 |
| Dec 31, 2023 | 122 | 4 | 3.39% | 120 | 2 |
| Dec 31, 2022 | 118 | -60 | -33.71% | 116 | 2 |
| Dec 31, 2021 | 178 | 32 | 21.92% | 174 | 4 |
| Dec 31, 2020 | 146 | -14 | -8.75% | 144 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Maravai LifeSciences Holdings | 550 |
| Arvinas | 430 |
| UroGen Pharma | 287 |
| Xencor | 250 |
| Geron | 229 |
| Annexon | 99 |
| Janux Therapeutics | 81 |
| ArriVent BioPharma | 52 |
CTMX News
- 18 hours ago - Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development - GlobeNewsWire
- 6 days ago - Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics - Business Wire
- 13 days ago - CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 19 days ago - CytomX Therapeutics Announces Business Update and Company Milestones for 2026 - GlobeNewsWire
- 6 weeks ago - CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling - Seeking Alpha
- 2 months ago - CytomX Therapeutics to Present at Upcoming December Investor Conferences - GlobeNewsWire
- 2 months ago - CytomX Therapeutics: Leaning Into The Hype, But What's Next? - Seeking Alpha
- 2 months ago - CytomX Therapeutics to Present at the Jefferies London Healthcare Conference - GlobeNewsWire